Skip to main content

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

Journal of Bone and Mineral Metabolism volume 25, pages 419–422 (2007)Cite this article

Abstract

Fibroblast growth factor (FGF)23 was identified as a humoral factor involved in the development of several hypophosphatemic diseases. Subsequent studies indicated that FGF23 is a hormone regulating serum phosphate level. However, it is still unknown how the production and serum level of FGF23 are regulated. This study was designed to determine whether acute changes of serum phosphate modulate FGF23 levels in human. Four healthy volunteers participated in the study. In the phosphate infusion study, dibasic potassium phosphate was infused at a rate of 10 mEq/h for 4 h, and serum FGF23 levels were measured for up to 6 h after the start of the infusion. In the carbohydrate study, partially hydrolyzed starch corresponding to 150 g glucose was ingested and FGF23 levels were measured similarly for 6 h. Phosphate infusion significantly increased and carbohydrate ingestion decreased serum phosphate levels, respectively. However, FGF23 did not change by these maneuvers. It is concluded that acute changes of serum phosphate do not modify FGF23 levels in the healthy human.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. T Shimada S Mizutani T Muto T Yoneya R Hino S Takeda Y Takeuchi T Fujita S Fukumoto T Yamashita (2001) ArticleTitleCloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proc Natl Acad Sci U S A 98 6500–6505 Occurrence Handle11344269 Occurrence Handle10.1073/pnas.101545198 Occurrence Handle1:CAS:528:DC%2BD3MXktVWktLs%3D

    PubMed  Article  CAS  Google Scholar 

  2. ADHR Consortium (2000) ArticleTitleAutosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 345–348 Occurrence Handle10.1038/81664

    Article  Google Scholar 

  3. B Lorenz-Depiereux M Bastepe A Benet-Pages M Amyere J Wagenstaller U Muller-Barth K Badenhoop SM Kaiser RS Rittmaster AH Shlossberg JL Olivares C Loris FJ Ramos F Glorieux M Vikkula H Juppner TM Strom (2006) ArticleTitleDMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis Nat Genet 38 1248–1250 Occurrence Handle17033625 Occurrence Handle10.1038/ng1868 Occurrence Handle1:CAS:528:DC%2BD28XhtFeisbvN

    PubMed  Article  CAS  Google Scholar 

  4. JQ Feng LM Ward S Liu Y Lu Y Xie B Yuan X Yu F Rauch SI Davis S Zhang H Rios MK Drezner LD Quarles LF Bonewald KE White (2006) ArticleTitleLoss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism Nat Genet 38 1310–1315 Occurrence Handle17033621 Occurrence Handle10.1038/ng1905 Occurrence Handle1:CAS:528:DC%2BD28XhtFeisbjE

    PubMed  Article  CAS  Google Scholar 

  5. Y Yamazaki R Okazaki M Shibata Y Hasegawa K Satoh T Tajima Y Takeuchi T Fujita K Nakahara T Yamashita S Fukumoto (2002) ArticleTitleIncreased circulatory level of biologically active full-length FGF23 in patients with hypophosphatemic rickets/osteomalacia J Clin Endocrinol Metab 87 4957–4960 Occurrence Handle12414858 Occurrence Handle10.1210/jc.2002-021105 Occurrence Handle1:CAS:528:DC%2BD38Xos1ynsLk%3D

    PubMed  Article  CAS  Google Scholar 

  6. KB Jonsson R Zahradnik T Larsson KE White T Sugimoto Y Imanishi T Yamamoto G Hampson H Koshiyama O Ljunggren K Oba IM Yang A Miyauchi MJ Econs J Lavigne H Juppner (2003) ArticleTitleFibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia N Engl J Med 348 1656–1663 Occurrence Handle12711740 Occurrence Handle10.1056/NEJMoa020881 Occurrence Handle1:CAS:528:DC%2BD3sXjtFSnsbk%3D

    PubMed  Article  CAS  Google Scholar 

  7. A Benet-Pages P Orlik TM Strom B Lorenz-Depiereux (2005) ArticleTitleAn FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Hum Mol Genet 14 385–390 Occurrence Handle15590700 Occurrence Handle10.1093/hmg/ddi034 Occurrence Handle1:CAS:528:DC%2BD2MXkt1Wktw%3D%3D

    PubMed  Article  CAS  Google Scholar 

  8. K Araya S Fukumoto R Backenroth Y Takeuchi K Nakayama N Ito N Yoshii Y Yamazaki T Yamashita J Silver T Igarashi T Fujita (2005) ArticleTitleA novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis J Clin Endocrinol Metab 90 5523–5527 Occurrence Handle16030159 Occurrence Handle10.1210/jc.2005-0301 Occurrence Handle1:CAS:528:DC%2BD2MXhtFWjt7%2FF

    PubMed  Article  CAS  Google Scholar 

  9. I Chefetz R Heller A Galli-Tsinopoulou G Richard B Wollnik M Indelman F Koerber O Topaz R Bergman E Sprecher E Schoenau (2005) ArticleTitleA novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification Hum Genet 118 261–266 Occurrence Handle16151858 Occurrence Handle10.1007/s00439-005-0026-8 Occurrence Handle1:CAS:528:DC%2BD2MXht1aitLzK

    PubMed  Article  CAS  Google Scholar 

  10. T Larsson X Yu SI Davis MS Draman SD Mooney MJ Cullen KE White (2005) ArticleTitleA novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis J Clin Endocrinol Metab 90 2424–2427 Occurrence Handle15687325 Occurrence Handle10.1210/jc.2004-2238 Occurrence Handle1:CAS:528:DC%2BD2MXjsFWis7g%3D

    PubMed  Article  CAS  Google Scholar 

  11. T Shimada M Kakitani Y Yamazaki H Hasegawa Y Takeuchi T Fujita S Fukumoto K Tomizuka T Yamashita (2004) ArticleTitleTargeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 561–568 Occurrence Handle14966565 Occurrence Handle10.1172/JCI200419081 Occurrence Handle1:CAS:528:DC%2BD2cXhsFKhsbs%3D

    PubMed  Article  CAS  Google Scholar 

  12. D Sitara MS Razzaque M Hesse S Yoganathan T Taguchi RG Erben H Juppner B Lanske (2004) ArticleTitleHomozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice Matrix Biol 23 421–432 Occurrence Handle15579309 Occurrence Handle10.1016/j.matbio.2004.09.007 Occurrence Handle1:CAS:528:DC%2BD2cXhtVaqsLnI

    PubMed  Article  CAS  Google Scholar 

  13. A Gupta K Winer MJ Econs SJ Marx MT Collins (2004) ArticleTitleFGF23 is elevated by chronic hyperphosphatemia J Clin Endocrinol Metab 89 4489–4492 Occurrence Handle15356053 Occurrence Handle10.1210/jc.2004-0724 Occurrence Handle1:CAS:528:DC%2BD2cXnslWhtL0%3D

    PubMed  Article  CAS  Google Scholar 

  14. TJ Weber S Liu OS Indridason LD Quarles (2003) ArticleTitleSerum FGF23 levels in normal and disordered phosphorus homeostasis J Bone Miner Res 18 1227–1234 Occurrence Handle12854832 Occurrence Handle10.1359/jbmr.2003.18.7.1227 Occurrence Handle1:CAS:528:DC%2BD3sXlsFGktL0%3D

    PubMed  Article  CAS  Google Scholar 

  15. T Larsson U Nisbeth O Ljunggren H Juppner KB Jonsson (2003) ArticleTitleCirculating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney Int 64 2272–2279 Occurrence Handle14633152 Occurrence Handle10.1046/j.1523-1755.2003.00328.x Occurrence Handle1:CAS:528:DC%2BD3sXpvFOqtLw%3D

    PubMed  Article  CAS  Google Scholar 

  16. Y Imanishi M Inaba K Nakatsuka K Nagasue S Okuno A Yoshihara A Miura A Miyauchi K Kobayashi T Miki T Shoji E Ishimura Y Nishizawa (2004) ArticleTitleFGF-23 in patients with end-stage renal disease on hemodialysis Kidney Int 65 1943–1946 Occurrence Handle15086938 Occurrence Handle10.1111/j.1523-1755.2004.00604.x Occurrence Handle1:CAS:528:DC%2BD2cXktl2gur8%3D

    PubMed  Article  CAS  Google Scholar 

  17. T Shigematsu JJ Kazama T Yamashita S Fukumoto T Hosoya F Gejyo M Fukagawa (2004) ArticleTitlePossible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency Am J Kidney Dis 44 250–256 Occurrence Handle15264182 Occurrence Handle10.1053/j.ajkd.2004.04.029 Occurrence Handle1:CAS:528:DC%2BD2cXnt1Srsrk%3D

    PubMed  Article  CAS  Google Scholar 

  18. Y Takeuchi H Suzuki S Ogura R Imai Y Yamazaki T Yamashita Y Miyamoto H Okazaki K Nakamura K Nakahara S Fukumoto T Fujita (2004) ArticleTitleVenous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia J Clin Endocrinol Metab 89 3979–3982 Occurrence Handle15292336 Occurrence Handle10.1210/jc.2004-0406 Occurrence Handle1:CAS:528:DC%2BD2cXmslKmu74%3D

    PubMed  Article  CAS  Google Scholar 

  19. SL Ferrari J-P Bonjour R Rizzoli (2005) ArticleTitleFibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men J Clin Endocrinol Metab 90 1519–1524 Occurrence Handle15613425 Occurrence Handle10.1210/jc.2004-1039 Occurrence Handle1:CAS:528:DC%2BD2MXisVOhsbY%3D

    PubMed  Article  CAS  Google Scholar 

  20. T Shimada Y Yamazaki M Takahashi H Hasegawa I Urakawa T Oshima K Ono M Kakitani K Tomizuka T Fujita S Fukumoto T Yamashita (2005) ArticleTitleVitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism Am J Physiol Renal Physiol 289 1088–1095 Occurrence Handle10.1152/ajprenal.00474.2004

    Article  Google Scholar 

  21. F Perwad N Azam MY Zhang T Yamashita HS Tenenhouse AA Portale (2005) ArticleTitleDietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice Endocrinology 146 5358–5364 Occurrence Handle16123154 Occurrence Handle10.1210/en.2005-0777 Occurrence Handle1:CAS:528:DC%2BD2MXht1OgurrK

    PubMed  Article  CAS  Google Scholar 

  22. H Yamashita T Yamashita M Miyamoto T Shigematsu JJ Kazama T Shimada Y Yamazaki S Fukumoto M Fukagawa S Noguchi (2004) ArticleTitleFibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism Eur J Endocrinol 151 55–60 Occurrence Handle15248822 Occurrence Handle10.1530/eje.0.1510055 Occurrence Handle1:CAS:528:DC%2BD2cXmsFelurk%3D

    PubMed  Article  CAS  Google Scholar 

  23. T Shimada H Hasegawa Y Yamazaki T Muto R Hino Y Takeuchi T Fujita K Nakahara S Fukumoto T Yamashita (2004) ArticleTitleFGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis J Bone Miner Res 19 429–435 Occurrence Handle15040831 Occurrence Handle10.1359/JBMR.0301264 Occurrence Handle1:CAS:528:DC%2BD2cXisFCrsbg%3D

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Division of Nephrology & Endocrinology, Department of Internal Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Nobuaki Ito, Seiji Fukumoto, Yasuhiro Takeuchi, Shu Takeda, Hisanori Suzuki & Toshiro Fujita

  2. Pharmaceutical Research Laboratories, Kirin Brewery Co. Ltd., Tokyo, Japan

    Takeyoshi Yamashita

Authors
  1. Nobuaki Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiji Fukumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhiro Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shu Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hisanori Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takeyoshi Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Toshiro Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seiji Fukumoto.

About this article

Cite this article

Ito, N., Fukumoto, S., Takeuchi, Y. et al. Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25, 419–422 (2007). https://doi.org/10.1007/s00774-007-0779-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-007-0779-3

Key words

  • FGF23
  • hyperphosphatemia
  • hypophosphatemia